NDC properties for NDC 9 0093-3750
NDC item 00093375004
| NDC 9 | 0093-3750 |
|---|---|
| NDC 10 | 0093-3750-04 |
| NDC Item | 00093375004 |
| ANDA | ANDA210915 |
| FDA SPL set id | 861937 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-09-15 |
| Marketing status | ACTIVE |
NDC item 00093375028
| NDC 9 | 0093-3750 |
|---|---|
| NDC 10 | 0093-3750-28 |
| NDC Item | 00093375028 |
| packaging | 7 POUCH in 1 CARTON (0093-3750-28) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| ANDA | ANDA210915 |
| FDA SPL set id | 861937 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-09-15 |
| Marketing status | ACTIVE |
NDC item 00093375063
| NDC 9 | 0093-3750 |
|---|---|
| NDC 10 | 0093-3750-63 |
| NDC Item | 00093375063 |
| packaging | 14 POUCH in 1 CARTON (0093-3750-63) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| ANDA | ANDA210915 |
| FDA SPL set id | 861937 |
| Labeler | Teva Pharmaceuticals USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-09-15 |
| Marketing status | ACTIVE |
NDC item 66993019544
| NDC 9 | 66993-195 |
|---|---|
| NDC 10 | 66993-195-44 |
| NDC Item | 66993019544 |
| FDA SPL set id | 696730 |
| Labeler | Prasco, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2020-09-15 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA201820 |
NDC item 66993019594
| NDC 9 | 66993-195 |
|---|---|
| NDC 10 | 66993-195-94 |
| NDC Item | 66993019594 |
| packaging | 14 POUCH in 1 CARTON (66993-195-94) / 4 AMPULE in 1 POUCH / 4 mL in 1 AMPULE |
| FDA SPL set id | 696730 |
| Labeler | Prasco, LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2020-09-15 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA201820 |
NDC item 70756061744
| NDC 9 | 70756-617 |
|---|---|
| NDC 10 | 70756-617-44 |
| NDC Item | 70756061744 |
| packaging | 4 in 1 POUCH |
| packaging | 4 mL in 1 AMPULE |
| ANDA | ANDA216725 |
| FDA SPL set id | 702891 |
| Labeler | Lifestar Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-23 |
| Marketing status | ACTIVE |
NDC item 70756061756
| NDC 9 | 70756-617 |
|---|---|
| NDC 10 | 70756-617-56 |
| NDC Item | 70756061756 |
| packaging | 14 POUCH in 1 CARTON (70756-617-56) / 4 AMPULE in 1 POUCH (70756-617-44) / 4 mL in 1 AMPULE |
| ANDA | ANDA216725 |
| FDA SPL set id | 702891 |
| Labeler | Lifestar Pharma LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2022-09-23 |
| Marketing status | ACTIVE |
NDC item 72603063004
| NDC 9 | 72603-630 |
|---|---|
| NDC 10 | 72603-630-04 |
| NDC Item | 72603063004 |
| packaging | 4 in 1 POUCH |
| packaging | 4 mL in 1 AMPULE |
| ANDA | ANDA216725 |
| FDA SPL set id | 801069 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-01 |
| Marketing status | ACTIVE |
NDC item 72603063056
| NDC 9 | 72603-630 |
|---|---|
| NDC 10 | 72603-630-56 |
| NDC Item | 72603063056 |
| packaging | 14 POUCH in 1 CARTON (72603-630-56) / 4 AMPULE in 1 POUCH (72603-630-04) / 4 mL in 1 AMPULE |
| ANDA | ANDA216725 |
| FDA SPL set id | 801069 |
| Labeler | NorthStar RxLLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2024-08-01 |
| Marketing status | ACTIVE |